Quarterly report pursuant to Section 13 or 15(d)

Composition of Certain Financial Statement Captions (Details)

v3.3.0.814
Composition of Certain Financial Statement Captions (Details) - USD ($)
$ in Thousands
Sep. 30, 2015
Dec. 31, 2014
Accounts receivable, net    
Accounts receivable $ 198,840 $ 21,875
Less: allowance for doubtful accounts (9,115) (1,906)
Accounts receivable, net 189,725 19,969 [1]
Inventories, net    
Consumable supplies 21,119 279
Finished products 13,851 11,837
Work in-process 1,045 1,011
Raw materials 5,472 4,116
Less: inventory reserve (794) (639)
Inventory, net 40,693 16,604 [1]
Prepaid expenses and other current assets    
Deferred tax assets 55,527 1,892
Prepaid supplies 9,298 1,123
Other receivables 3,995 669
Taxes recoverable 3,083 2,417
Other 2,357 2,320
Prepaid insurance 594 968
Prepaid expenses and other current assets 74,854 9,389 [1]
Intangible assets, net:    
Less: accumulated amortization (45,966) (33,931)
Intangible assets, net 660,287 62,649 [1]
Accrued expenses:    
Deferred revenue 75,763 4,185
Employee benefits 31,668 4,127
Contingent consideration 28,283 27,352
Taxes payable 24,024 77
Capital leases short-term 10,785 0
Clinical trials 4,351 8,643
Professional fees 1,375 1,860
Milestone payment 5,000 0
Other 19,864 14,668
Accrued expenses 201,113 60,912 [1]
Other long-term liabilities:    
Deferred revenue 178,308 2,526
Mortgages and other debts payable 4,735 2,434
Capital leases long-term 7,120 0
Other 18,738 1,030
Other long-term liabilities 236,476 50,205
OPKO Renal    
Other long-term liabilities:    
Contingent consideration 19,210 36,529
OPKO Health Europe    
Other long-term liabilities:    
Contingent consideration 232 254
OPKO Diagnostics    
Other long-term liabilities:    
Contingent consideration 7,683 6,992
CURNA    
Other long-term liabilities:    
Contingent consideration 450 440
Customer relationships    
Intangible assets, net:    
Intangible assets 451,030 22,108
Technologies    
Intangible assets, net:    
Intangible assets 151,791 52,508
Trade names    
Intangible assets, net:    
Intangible assets 50,431 3,483
Licenses    
Intangible assets, net:    
Intangible assets 25,399 572
Covenants not to compete    
Intangible assets, net:    
Intangible assets 8,618 8,639
Product registrations    
Intangible assets, net:    
Intangible assets 7,642 8,763
Other    
Intangible assets, net:    
Intangible assets $ 11,342 $ 507
[1] As of December 31, 2014, total assets include $7.6 million and total liabilities include $12.1 million related to SciVac Ltd (“SciVac”). SciVac was a consolidated variable interest entity which we deconsolidated in July 2015. Refer to Note 5. SciVac’s consolidated assets were owned by SciVac and SciVac’s consolidated liabilities had no recourse against us.